Bill > A07501

This bill adds tianeptine sodium to Schedule II of controlled substances in the New York public health law. Tianeptine is a chemical compound originally developed as an antidepressant, but it has recently gained attention for its potential for abuse and harmful side effects. By placing it in Schedule II, the bill classifies tianeptine sodium as a substance with a high potential for abuse that can lead to severe psychological or physical dependence, and which has a currently accepted medical use with strict restrictions. The bill amends the existing public health law by inserting a new paragraph specifically listing tianeptine sodium in the Schedule II category, signaling the state's intent to regulate and control this substance. The legislation will take effect 90 days after it becomes law, giving state agencies and medical professionals time to prepare for the new classification and associated regulations.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/A7501